Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14ARF and p53 binding

Leukemia and Lymphoma

Volumn 44, Issue 9, 2003, Pages 1587-1596

  Stürzenhofecker, Benjamin ^a   Schlott, Thilo ^a   Quentin, Thomas ^a   Kube, Dieter ^a   Jung, Wolfram ^a   Trümper, Lorenz ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Co localization; HDM2; Hodgkin lymphoma cells; p14ARF; p53; Splicing

Indexed keywords

ONCOPROTEIN; PROTEIN MDM2; PROTEIN P14; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CELL NUCLEUS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA INTEGRATION; DNA SEQUENCE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOMA CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN VARIANT;

ALTERNATIVE SPLICING; BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REED-STERNBERG CELLS; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17944390587     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000103962     Document Type: Article

References (48)

1. Poppema, S. and van den, B.A. (2000) "Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas", Semin. Cancer Biol. 10, 345-350.
2. Bargou, R.C., Leng, C., Krappmann, D., Emmerich, F., Mapara, M.Y., Bommert, K., Royer, H.D., Scheidereit, C. and Dorken, B. (1996) "High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells", Blood 87, 4340-4347.
3. Kuppers, R. (1999) "Identifying the precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease: role of the germinal center in B-cell lymphomagenesis", J. Acquir. Immune Defic. Syndr. 21(Suppl. 1), S74-S79.
4. Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P.C., Diehl, V. and Tesch, H. (2001) "STAT3 is constitutively activated in Hodgkin cell lines", Blood 98, 762-770.
5. Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B. and Scheidereit, C. (2001) "Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86 and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells", Blood 97, 2798-2807.
6. Villuendas, R., Piris, M.A., Orradre, J.L., Mollejo, M., Algara, P., Sanchez, L., Martinez, J.C. and Martinez, P. (1992) "P53 protein expression in lymphomas and reactive lymphoid tissue", J. Pathol. 166, 235-241.
7. Trumper, L.H., Brady, G., Bagg, A., Gray, D., Loke, S.L., Griesser, H., Wagman, R., Braziel, R., Gascoyne, R.D. and Vicini, S. (1993) "Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations", Blood 81, 3097-3115.
8. Kopper, M., Joos, S., von Bonin, F., Daus, H., Pfreudschuh, M., Lichter, P. and Trumper, L. (2001) "HDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies", Br. J. Haematol. 112, 768-775.
9. Blagosklonny, M.V. (1997) "Loss of function and p53 protein stabilization", Oncogene 15, 1889-1893.
10. Bosari, S., Viale, G., Roncalli, M., Graziani, D., Borsani, G., Lee, A.K. and Coggi, G. (1995) "p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma", Am. J. Pathol. 147, 790-798.
11. Levine, A.J. (1997) "p53, the cellular gatekeeper for growth and division", Cell 88, 323-331.
12. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) "Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis", Cancer Res. 54, 4855-4978.
13. Miyashita, T. and Reed, J.C. (1995) "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", Cell 80, 293-299.
14. el Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) "WAF1, a potential mediator of p53 tumor suppression", Cell 75, 817-825.
15. Momand, J., Zambetti, G.P., Olson, D.C., George, D. and Levine, A.J. (1992) "The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation", Cell 69, 1237-1245.
16. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W. and Vogelstein, B. (1993) "Oncoprotein HDM2 conceals the activation domain of tumour suppressor p53", Nature 362, 857-860.
17. Kubbutat, M.H., Jones, S.N. and Vousden, K.H. (1997) "Regulation of p53 stability by Hdm2", Nature 387, 299-303.
18. Fang, S., Jensen, J.P., Ludwig, R.L., Vousden, K.H. and Weissman, A.M. (2000) "Hdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53", J. Biol. Chem. 275, 8945-8951.
19. Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T. and Levine, A.J. (1996) "The HDM2 oncoprotein binds specifically to RNA through its RING finger domain", Mol. Med. 2, 439-451.
20. Lohrum, M.A., Ashcroft, M., Kubbutat, M.H. and Vousden, K.H. (2000) "Identification of a cryptic nucleolar-localization signal in HDM2", Nat. Cell Biol. 2, 179-181.
21. Freedman, D.A., Epstein, C.B., Roth, J.C., Levine, A.J., "A genetic approach to mapping the p53 binding site in the HDM2 protein", Mol. Med. 3, 248-259.
22. Honda, R., Tanaka, H. and Yasuda, H. (1997) "Oncoprotein HDM2 is a ubiquitin ligase E3 for tumor suppressor p53", FEBS Lett. 420, 25-27.
23. Kubbutat, M.H., Ludwig, R.L., Ashcroft, M. and Vousden, K.H. (1998) "Regulation of Hdm2-directed degradation by the C terminus of p53", Mol. Cell Biol. 18, 5690-5698.
24. Picksley, S.M. and Lane, D.P. (1993) "The p53-hdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?", Bioessays 15, 689-690.
25. Zhang, Y., Xiong, Y. and Yarbrough, W.G. (1998) "ARF promotes HDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways", Cell 92, 725-734.
26. Newcomb, E.W., Alonso, M., Sung, T. and Miller, D.C. (2000) "Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas", Hum. Pathol. 31, 115-119.
27. Zhang, Y. and Xiong, Y. (1999) "Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of HDM2 and p53", Mol. Cell 3, 579-591.
28. Esteller, M., Cordon-Cardo, C., Corn, P.G., Meltzer, S.J., Pohar, K.S., Watkins, D.N., Capella, G., Peinado, M.A., Matias-Guiu, X., Prat, J., Baylin, S.B. and Herman, J.G. (2001) "p14ARF silencing by promoter hypermethylation mediated abnormal intracellular localization of HDM2", Cancer Res. 61, 2816-2821.
29. Roijer, E., Nordkvist, A., Strom, A.K., Ryd, W., Behrendt, M., Bullerdiek, J., Mark, J. and Stenman, G. (2002) "Translocation, deletion/amplification, and expression of HMGIC and HDM2 in a carcinoma expleomorphic adenoma", Am. J. Pathol. 160, 433-440.
30. Sigalas, I., Calvert, A.H., Anderson, J.J., Neal, D.E. and Lunec, J. (1996) "Alternatively spliced hdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer", Nat. Med. 2, 912-917.
31. Matsumoto, R., Tada, M., Nozaki, M., Zhang, C.L., Sawamura, Y. and Abe, H. (1998) "Short alternative splice transcripts of the hdm2 oncogene correlate to malignancy in human astrocytic neoplasms", Cancer Res. 58, 609-613.
32. Kraus, A., Neff, F., Behn, M., Schuermann, M., Muenkel, K. and Schlegel, J. (1999) "Expression of alternatively spliced hdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells", Int. J. Cancer 80, 930-934.
33. Evdokiou, A., Atkins, G.J., Bouralexis, S., Hay, S., Raggatt, L.J., Cowled, P.A., Graves, S.E., Clayer, M. and Findlay, D.M. (2001) "Expression of alternatively-spliced HDM2 transcripts in gaint cell tumors of bone", Int. J. Oncol. 19, 625-632.
34. Tamborini, E., Della, T.G., Lavarino, C., Azzarelli, A., Carpinelli, P., Pierotti, M.A. and Pilotti, S. (2001) "Analysis of the molecular species generated by HDM2 gene amplification in liposarcomas", Int. J. Cancer 92, 790-796.
35. Bartel, F., Taylor, A.C., Taubert, H. and Harris, L.C. (2001) "Novel hdm2 splice variants identified in pediatric rhabdomysarcoma tumors and cell lines", Onocol. Res. 12, 451-457.
36. Bartel, F., Meye, A., Wurl, P., Kappler, M., Bache, M., Lautenschlager, C., Grunbaum, U., Schmidt, H. and Taubert, H. (2001) "Amplification of the HDM2 gene, but not expression of splice variants of HDM2 MRNA, is associated with prognosis in soft tissue sarcoma", Int. J. Cancer 95, 168-175.
37. Lukas, J., Gao, D.Q., Keshmeshian, M., Wen, W.H., Tsao-Wei, D., Rosenberg, S. and Press, M.F. (2001) "Alternative and aberrant messenger RNA splicing of the hdm2 oncogene in invasive breast cancer", Cancer Res. 61, 3212-3219.
38. Joos, S., Menz, C.K., Wrobel, G., Siebeert, R., Gesk, S., Ohl, S., Mechtersheimer, G., Trumper, L., Moller, P., Lichter, P. and Barth, T.F. (2002) "Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2", Blood 99, 1381-1387.
39. Tzardi, M., Kouvidou, C., Panayiotides, I., Koutsoubi, K., Stefanaki, K., Giannikaki, E., Darivianaki, K., Zois, M., Eliopoulos, G., Kakolyris, S., Delides, G., Rontogianni, D. and Kanavaros, P. (1996) "Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus", Anticancer Res. 16, 2813-2819.
40. Elenitoba-Johnson, K.S., Medeiros, L.J., Khorsand, J. and King, T.C. (1996) "P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease", Am. J. Clin. Pathol. 106, 728-738.
41. Garcia, J.F., Villuendas, R., Sanchez-Beato, M., Sanchez-Aguilera, A., Sanchez, L., Prieto, I. and Piris, M.A. (2002) "Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts", Am. J. Pathol. 160, 569-578.
42. Chen, L., Marechal, V., Moreau, J., Levine, A.J. and Chen, J. (1997) "Proteolytic cleavage of the hdm2 oncoprotein during apoptosis", J. Biol. Chem. 272, 22966-22973.
43. Chin, P.L., Momand, J. and Pfeifer, G.P. (1997) "In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation", Oncogene 15, 87-99.
44. Girinsky, T., Koumenis, C., Graeber, T.G., Peehl, D.M. and Giaccia, A.J. (1995) "Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents", Cancer Res. 55, 3726-3731.
45. Evans, S.C., Viswanathan, M., Grier, J.D., Narayana, M., El Naggar, A.K. and Lozano, G. (2001) "An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2", Oncogene 20, 4041-4049.
46. Ohshima, K., Haraoka, S., Fujiki, T., Yoshioka, S., Suzumiya, J., Kanda, M. and Kikuchi, M. (1999) "Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclindependent kinase inhibitor p21 expression", Pathol. Int. 49, 506-512.
47. Dang, J., Kuo, M.L., Eischen, C.M., Stenpanova, L., Sherr, C.J. and Roussel, M.F. (2002) "The RING domain of Hdm2 can inhibit cell proliferation", Cancer Res. 62, 1222-1230.
48. Sherr, C.J. (1993) "Mammalian G1 cyclins", Cell 73, 1059-1065.